6-α-Methyl-20-oxopregn-4-en-17-α-ylacetat

6-α-Methyl-20-oxopregn-4-en-17-α-ylacetat Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Progestin.

Weltgesundheitsorganisation (WHO)

Anagestone acetate, a synthetic progestogen, was introduced in 1968 as a component in oral contraceptive preparations. In 1969, it was shown to be associated with an increased risk of mammary tumours in dogs which led the United States Food and Drug Administration to order the termination of its use in all clinical trials. Subsequently the manufacturer withdrew preparations containing anagestone acetate, ultimately on a worldwide basis.

6-α-Methyl-20-oxopregn-4-en-17-α-ylacetat Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

6-α-Methyl-20-oxopregn-4-en-17-α-ylacetat Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Hubei Yangxin Medical Technology Co., Ltd.	15374522761	3003392093@qq.com	China	7851	55

---

• 6-alpha-methyl-20-oxopregn-4-en-17-alpha-yl acetate
• 17-Acetyloxy-6α-methylpregn-4-en-20-one
• Anatropin
• Pregn-4-en-20-one, 17-(acetyloxy)-6-methyl-, (6α)-
• Centhaquin Impurity 46
• 3137-73-3